Cimerli Prior Authorization Resources

Find the right PA form for your patient's payer, get the ICD-10 codes you need, and download appeal templates — all in one place.

Accredo - Specialty Pharmacy Referral FormAccredo
Blue Cross Blue Shield of Arkansas - Pharmacy Prior Authorization Form Arkansas Blue Cross Blue Shield
Blue Cross Blue Shield of Illinois - Anti-VEGF Prior Authorization Request FormBlue Cross Blue Shield of Illinois
Blue Cross Blue Shield of Michigan - Ranibizumab Medical Authorization Request FormBlue Cross Blue Shield of Michigan
Blue Cross of Idaho - General Prior Authorization Form Blue Cross of Idaho Health Services, Inc.
California - Uniform Prior Authorization FormCalifornia

ICD-10 codes for Cimerli Prior Authorizations

H35.32Exudative age-related macular degeneration
H34.81Central retinal vein occlusion
H34.9Unspecified retinal vascular occlusion
E10.321Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema
E11.321Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema
E13.321Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema
E10.32Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy
E11.32Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy
E13.32Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy
H44.2ADegenerative myopia with choroidal neovascularization

Appeal Templates

If the payer denies coverage, these templates help you build a stronger appeal.
Coverage Authorization Appeals Coverage Authorization Appeals resource
Letter of Medical Necessity Letter of Medical Necessity resource
A peer-to-peer review with the payer's medical director can often resolve denials faster than a formal appeal.

Support for Getting Your Patient on Cimerli

Check coverage & formulary statusVerify PA requirements for your patient's plan.Find savings programsCopay cards, patient assistance, and more.Check medication interactionsScreen prescriptions for harmful drug combinations.